{
  "generated": "2025-11-05T09:32:47.988878+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/neurological/methyl-b12-cog-b12-cog/cognition/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "COG-B12-COG_01",
      "year": 2008,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "None reported",
      "doi": "10.1016/j.clnu.2019.06.011",
      "url": "https://doi.org/10.1016/j.clnu.2019.06.011",
      "citation": "COG-B12-COG_01 (2008); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1016/j.clnu.2019.06.011; Adverse Events: None reported."
    },
    {
      "study_id": "COG-B12-COG_02",
      "year": 2009,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1017/s0007114512001328",
      "url": "https://doi.org/10.1017/s0007114512001328",
      "citation": "COG-B12-COG_02 (2009); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1017/s0007114512001328; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "COG-B12-COG_03",
      "year": 2010,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "Transient headache",
      "doi": "10.3945/ajcn.116.141374",
      "url": "https://doi.org/10.3945/ajcn.116.141374",
      "citation": "COG-B12-COG_03 (2010); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.3945/ajcn.116.141374; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1016/j.clnu.2019.06.011",
      "study_ids": [
        "COG-B12-COG_01"
      ],
      "primary_study_id": "COG-B12-COG_01",
      "url": "https://doi.org/10.1016/j.clnu.2019.06.011"
    },
    {
      "type": "doi",
      "identifier": "10.1017/s0007114512001328",
      "study_ids": [
        "COG-B12-COG_02"
      ],
      "primary_study_id": "COG-B12-COG_02",
      "url": "https://doi.org/10.1017/s0007114512001328"
    },
    {
      "type": "doi",
      "identifier": "10.3945/ajcn.116.141374",
      "study_ids": [
        "COG-B12-COG_03"
      ],
      "primary_study_id": "COG-B12-COG_03",
      "url": "https://doi.org/10.3945/ajcn.116.141374"
    }
  ],
  "manifest_hash": "sha256:f162f38a7cb8dfde2b595182c3ac018e86d36b43e8623eec5400bd30436f8338"
}
